Computed Tomography-Derived Liver Surface Nodularity and Sarcopenia as Prognostic Factors in Patients with Resectable Metabolic Syndrome-Related Hepatocellular Carcinoma.

MLA

Seror, Martin, et al. “Computed Tomography-Derived Liver Surface Nodularity and Sarcopenia as Prognostic Factors in Patients with Resectable Metabolic Syndrome-Related Hepatocellular Carcinoma.” Annals of Surgical Oncology, vol. 28, no. 1, Jan. 2021, pp. 405–16. EBSCOhost, https://doi.org/10.1245/s10434-020-09143-9.

APA

Seror, M., Sartoris, R., Hobeika, C., Bouattour, M., Paradis, V., Rautou, P.-E., Soubrane, O., Vilgrain, V., Cauchy, F., & Ronot, M. (2021). Computed Tomography-Derived Liver Surface Nodularity and Sarcopenia as Prognostic Factors in Patients with Resectable Metabolic Syndrome-Related Hepatocellular Carcinoma. Annals of Surgical Oncology, 28(1), 405–416. https://doi.org/10.1245/s10434-020-09143-9

Chicago

Seror, Martin, Riccardo Sartoris, Christian Hobeika, Mohamed Bouattour, Valérie Paradis, Pierre-Emmanuel Rautou, Olivier Soubrane, Valérie Vilgrain, François Cauchy, and Maxime Ronot. 2021. “Computed Tomography-Derived Liver Surface Nodularity and Sarcopenia as Prognostic Factors in Patients with Resectable Metabolic Syndrome-Related Hepatocellular Carcinoma.” Annals of Surgical Oncology 28 (1): 405–16. doi:10.1245/s10434-020-09143-9.